Nonresponders to Daily Paroxetine and Another SSRI in Men With Lifelong Premature Ejaculation: A Pharmacokinetic Dose-Escalation Study for a Rare Phenomenon

PURPOSE: Nonresponse to any selective serotonin reuptake inhibitor (SSRI) treatment is rare. In this study, we aimed to investigate ejaculation delay nonresponse to paroxetine treatment in men with lifelong premature ejaculation (PE) who were also known to be nonresponders to other SSRIs. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, Paddy KC, Touw, Daan, Schweitzer, Dave H., Waldinger, Marcel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165923/
https://www.ncbi.nlm.nih.gov/pubmed/25237462
http://dx.doi.org/10.4111/kju.2014.55.9.599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165923/
https://www.ncbi.nlm.nih.gov/pubmed/25237462
http://dx.doi.org/10.4111/kju.2014.55.9.599

Ejemplares similares